Drugs & medicalClass II

EPI Health, LLC recalls minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited,…

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Read the official notice →
Date
2024-05-01
Country
United States
Brand
EPI Health, LLC
Product
minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited,…
Classification
Class II
Units
US Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2024-05-01
  2. US
    Drugs & medicalClass II

    Siemens Medical Solutions USA, Inc. recalls ACUSON Redwood 1.0 Diagnostic Ultrasound System, REF: 11503314, running software version VA10A to VA10G

    On ultrasound systems, when Cardiac DICOM SR feature is configured to display either minimum or maximum measured value, and multiple cardiac region measurements are made, and results are exported into the SR feature,…

    FDA · DeviceSiemens Medical Solutions USA, Inc.Worldwide distribution - US Nationwide including in the states of AL, AR, CA,…Official notice →
  3. US
    Drugs & medicalClass I

    Biomerieux Inc recalls VITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REF 418984; b) AST-GN95, REF…

    Ceftriaxone (cro02n) concentration errors associated with specific recently manufactured test kits which would have the potential for for false susceptible results. The risk is present for isolates that have a result…

    FDA · DeviceBiomerieux IncWorldwideOfficial notice →
  4. US
    Drugs & medicalClass II

    LEICA BIOSYSTEMS NUSSLOCH GMBH recalls Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED)

    There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set for created or…

    FDA · DeviceLEICA BIOSYSTEMS NUSSLOCH GMBHUS, NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,…

    Failed Dissolution Specifications

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide in the USA.Official notice →
  6. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30…

    Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.

    FDA · DrugCipla USA, Inc.USA nationwide.Official notice →
  7. US
    Drugs & medicalClass I

    FA Online Inc recalls ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.

    Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this unapproved drug.

    FDA · DrugFA Online IncUSA Nationwide. The product was sold via Amazon Market Place.Official notice →
See all drugs & medical recalls →